ESR1 and breast carcinoma: The most important conclusion from our work is that among the fusion transcripts evaluated measuring ESR1-CCDC170 exon 8 fusion transcripts in primary breast cancers has diagnostic potential as it identifies a more aggressive subset of ER-positive breast cancer patients.